Performance of Certest Biotec’s VIASURE yellow fever real time PCR detection kit: assessment report and recommendations for use in surveillance

Overview

On a need’s basis, the Immunization Analysis and Insights, Vaccine Preventable Diseases (VPD) Surveillance and Risk Assessment Team of the World Health Organization (WHO) posts expression of interest (EOI) calls, inviting manufacturers of specified technologies (in vitro diagnostics also known as IVDs) to participate in a WHO product evaluation. The focus is on IVDs that are used by WHO’s laboratory networks undertaking surveillance for certain VPDs.

The WHO Kit Performance Evaluation Programme outcomes generate information on product suitability for WHO’s laboratory networks undertaking the surveillance of VPDs and are reported in public reports. The current report outlines the outcome of such evaluation programme undertaken for the VIASURE Yellow Fever Real Time PCR Detection Kit (manufactured by Certest Biotec S.L.) for the specific identification of Yellow fever in clinical samples from patients with signs and symptoms of Yellow virus infection in the context of surveillance. This is the second commercially available RT-qPCR assay recommended by WHO for the detection of yellow fever virus in the context of surveillance. Read more about Certest Biotec’s VIASURE yellow fever real time PCR detection kit - Assessment report and recommendations for use in surveillance in the attached public report.